🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Residual Neuromuscular Block in the Post-Anesthetic Unit and Postoperative Complications

Recruitingn/aAges 18 Years - anyAllHospital Universitario de Gran Canaria Doctor Neg…
NCT06386354 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The use of neuromuscular blockers (NMB) is essential to optimize surgical conditions, ensure patient immobility during the intervention and prevent complications derived from involuntary movements. Intraoperative monitoring of neuromuscular relaxation allows the depth of neuromuscular blockade to be accurately evaluated, guaranteeing ideal conditions for the surgical team. Residual neuromuscular blockade (RNMB) is the persistence of muscle paralysis after the administration of NMB during a surgical intervention. The appearance of RNMB poses substantial challenges in the postoperative period, as it has negative repercussions for the safety and well-being of the patient.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient undergoing surgical intervention under general anesthesia that requires the use of neuromuscular block during the study time and that required hospital admission. * Informed consent signature. Exclusion Criteria: * Neuromuscular disease * Not having received neuromuscular block during the intervention * Admission to the outpatient surgery unit * Admission to the postoperative intensive care unit * Patients who signed informed consent, but postoperative data could not be collected upon arrival at the PACU.
💊

What it tests

  • Train-of-four
📍

Where

2 sites
Hospital Universitario de Gran Canaria Doctor Negrín
Las Palmas de Gran Canaria, Spain
Ángel Becerra
Las Palmas de Gran Canaria, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy